CME/CE
129-144 of 173
MinuteCE®The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program credits
Prof. Kausik Ray
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesKausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
Gianluigi Savarese, MD
Gianluigi Savarese, MD, PhD, FESC, FHFA
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
Ulrich Laufs, MD, PhD
Pasquale Perrone-Filardi, MD, PhD
Carolyn Lam, MD, PhD
Scott Solomon, MD
Mikhail Kosiborod, MD
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin Michos
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Roberto Barriales-Villa, MD, PhD
Perry Elliott, MD
Roberto Barriales-Villa, MD, PhD
Iacopo Olivotto, MD
Perry Elliott, MD
Eric D. Austin, MD, MSCI
Hilary M. DuBrock, MD
H. James Ford, MD
Gustavo A. Heresi, MD, MS
Gergely Meszaros, JD, MSc
Oksana A. Shlobin, MD
Ioana Preston, MD
Lucilla Piccari, MD, PhD
